Clinical Trial Details


Research Study Summary

Are your numbers under control


Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, for Treatment of Stage 1 or 2 Hypertension

Patient Inclusion Criteria:

  • Male or female outpatients of age 18 years or above
  • Patients diagnosed with stage 1 or stage 2 essential hypertension
  • Normal physical examination findings, electrocardiogram (ECG) results and chest x-ray; or abnormal findings judged by the Investigator to be not clinically significant

Patient Exclusion Criteria:

  • Secondary hypertension or severe hypertension
  • Clinically significant cardiovascular disease or heart failure
  • Clinical significant respiratory disease that would prohibit the use of a beta blocker
  • A medical contraindication to discontinuing a current antihypertensive therapy
  • History of Type 1 diabetes mellitus
  • History of Severe Mental Illness except mild depression

To Learn more

CW ID: 180205
Date Last Changed: July 19, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Luis Sanchez, Study Coordinator
Central Medical Group, P.A Research
6610 N. University Drive
Suite 120
Tamarac, FL 33321
Phone: 954-720-7211

View Map

Research Center Information:

Central Medical Group, P.A Research

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.